MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
213 hedge funds and large institutions have $3.53B invested in Mirati Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 94 increasing their positions, 50 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
21% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 38
3% more funds holding
Funds holding: 207 → 213 (+6)
Holders
213
Holding in Top 10
9
Calls
$75.7M
Puts
$23.3M
Top Buyers
| 1 | +$250M | |
| 2 | +$100M | |
| 3 | +$61.2M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$52.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$51.2M |
Top Sellers
| 1 | -$114M | |
| 2 | -$26M | |
| 3 | -$20.5M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$19M |
| 5 |
Morgan Stanley
New York
|
-$16.7M |